dm+d

Unassigned

New Medicines

AmpionOsteoarthritis of the knee

Information

Ampion
New molecular entity
Ampio Pharmaceuticals
Ampio Pharmaceuticals

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Ampion is a non-steroidal anti-inflammatory biologic; active ingredient DA-DKP is derived from 2 amino acids from human albumin and appears to have a significant role in the homeostasis of inflammation
About 6% of adults aged 30 have frequent knee pain and radiographic evidence of osteoarthritis (OA). Symptomatic knee OA affects 12% of people over the age of 65. [2]
Osteoarthritis of the knee
Intraarticular

Evidence based evaluations